Navigation Links
Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President
Date:12/1/2009

PLEASANTON, Calif., Dec. 1 /PRNewswire/ -- The new position of Executive Vice President, Commercial Affairs at Microchip Biotechnologies, Inc. has been taken up by Howard Goldstein, a biotech lab systems executive with more than 30 years of experience creating and managing life science product organizations. Mr. Goldstein will direct Microchip Biotechnologies' marketing, business development, sales and customer service operations as the company makes the transition from product development to full commercial operations.

"Howard adds directly relevant strategic, operational, and commercial experience to our executive profile," said Stevan Jovanovich, President/CEO of Microchip Biotechnologies. "His leadership and expertise will be keys to the realization of our commercial growth objectives."

Prior to joining Microchip Biotechnologies, Mr. Goldstein first served as Chief Executive Officer and then Chief Commercial Officer of Arcxis Biotechnologies, and was Managing Partner of Practical Marketing and Sales, a biotech business consultancy. He has been responsible for building and directing marketing, engineering, and sales teams that have created more than 10 key product categories in the research marketplace. Mr. Goldstein received his MBA degree in Organizational Development from Temple University, Philadelphia, PA and an M.Sc. degree in Biochemistry from the University of Dayton, Dayton OH.

About Microchip Biotechnologies, Inc.

Microchip Biotechnologies, Inc. (MBI), headquartered in Pleasanton, CA is a venture-backed, privately held company that produces automated sample processing systems for life sciences, applied sciences, and healthcare diagnostics markets. The company's products are based on the Apollo fluidics technology platform, which integrates advanced fluidics and analytical capabilities to produce automated sample-to-answer systems for DNA and RNA sequencing, DNA-based forensics and human identity (HID) testing, biodefense, and molecular diagnostics applications. The company's first product, the Apollo 100 System, automates sample processing for Sanger cycle sequencing and dramatically reduces process requirements for expensive sequencing reagents. For additional information about MBI, visit http://www.microchipbiotech.com.


Contact: Howard D. Goldstein
Microchip Biotechnologies Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94568
(925) 701-3481
howard.goldstein@microchipbiotech.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE Microchip Biotechnologies, Inc.


'/>"/>
SOURCE Microchip Biotechnologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Scott Glenn Joins Exagen Diagnostics as Chairman and CEO
2. PFC Pharma Joins DATATRAKs CRO Connect Program
3. William Cork Joins Fenwal as Chief Technology Officer
4. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
5. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
6. American Lung Association of California Joins Sheriffs Department to Support Influenza Vaccination In Sacramento
7. Marsha Fanucci Joins Ironwood Board of Directors
8. Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
9. The Medco Foundation Joins With the Entertainment Industry Foundation to Give Health a Hand to Communities in Need
10. Dilon Diagnostics Joins Forces With Philips for Womens Health Solutions
11. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Consumers have taken a more ... placed more emphasis on patient outcomes. ... in the pharmaceutical industry have evolved beyond just ... companies are focusing on becoming more patient-oriented across ... and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... DDS, and Randall Markarian, DDS, are co-chairs for the Illinois State Dental Society ... Friday-Saturday, July 15-16 at the Gateway Convention Center in Collinsville. , ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... Foundation, a not-for-profit organization responsible for clinical transfusion research programs and for the ... the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , ...
(Date:6/23/2016)... ... June 23, 2016 , ... SyncDog, Inc. ... mobile security software, is featured in the current issue of Silicon Review ... companies with innovative technology solutions and features them in their magazine. The magazine ...
(Date:6/23/2016)... Newark, NJ (PRWEB) , ... June 23, 2016 ... ... declared today’s Appellate Court ruling a victory for consumers seeking relief from the ... Div., Docket No. A2913-15T2 & A2929-15T2. , In their ruling ( ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... A key ... DC area, which is one of the best known examples of areas that lack ... amassed almost a thousand daily users. , Any participant within the marijuana industry, ...
Breaking Medicine News(10 mins):